2017 60 day FRN

Federal Register / Vol. 82, No. 33 / Tuesday, February 21, 2017 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; H3A Bioinformatics.
Date: March 17, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 3rd Floor Conf. Room, 5635 Fishers
Lane, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Ken D. Nakamura, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Suite 4076, MSC 9306,
Rockville, MD 20852, 301–402–0838,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: February 14, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.

Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Emerging Science and
Technologies in Transplantation Research
(U01).
Date: March 14–15, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G51, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–507–9685,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 14, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03276 Filed 2–17–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0139]

[FR Doc. 2017–03280 Filed 2–17–17; 8:45 am]

Agency Information Collection
Activities: Electronic Visa Update
System

BILLING CODE 4140–01–P

AGENCY:

U.S. Customs and Border
Protection, Department of Homeland
Security
ACTION: 60-Day notice and request for
comments; revision of an existing
collection of information.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
sradovich on DSK3GMQ082PROD with NOTICES

as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

VerDate Sep<11>2014

17:15 Feb 17, 2017

Jkt 241001

U.S. Customs and Border
Protection (CBP) of the Department of
Homeland Security will be submitting
the following information collection
request to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act: Electronic Visa Update
System (EVUS). This is a proposed
extension and revision of an
information collection that was
previously approved. CBP is proposing

SUMMARY:

PO 00000

Frm 00067

Fmt 4703

Sfmt 4703

11237

that this information collection be
extended with a revision to the
information collected. This document is
published to obtain comments from the
public and affected agencies.
DATES: Written comments should be
received on or before April 24, 2017 to
be assured of consideration.
ADDRESSES: All submissions received
must include the OMB Control Number
1651–0139 in the subject line and the
agency name. To avoid duplicate
submissions, please use only one of the
following methods to submit comments:
(1) Email. Submit comments to: (CBP_
[email protected]). The email should
include the OMB Control number in the
subject line.
(2) Mail. Submit written comments to
CBP PRA Officer, U.S. Customs and
Border Protection, Office of Trade,
Regulations and Rulings, Economic
Impact Analysis Branch, 10th Floor, 90
K St NE., Washington, DC 20229–1177.
FOR FURTHER INFORMATION CONTACT:
Requests for additional PRA information
should be directed to Paperwork
Reduction Act Officer, U.S. Customs
and Border Protection, Regulations and
Rulings, Office of Trade, 90 K Street
NE., 10th Floor, Washington, DC 20229–
1177, or via email (CBP_PRA@
cbp.dhs.gov). Please note that the
contact information provided here is
solely for questions regarding this
notice. Individuals seeking information
about other CBP programs should
contact the CBP National Customer
Service Center at 877–227–5511, (TTY)
1–800–877–8339, or CBP Web site at
https://www.cbp.gov/. For additional
help: https://help.cbp.gov/app/home/
search/1.
SUPPLEMENTARY INFORMATION: CBP
invites the general public and other
Federal agencies to comment on
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.). The comments should address:
(a) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s
estimates of the burden of the collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden including the use
of automated collection techniques or
the use of other forms of information
technology; and (e) the annual cost
burden to respondents or record keepers
from the collection of information (total
capital/startup costs and operations and
maintenance costs). The comments that

E:\FR\FM\21FEN1.SGM

21FEN1

11238

Federal Register / Vol. 82, No. 33 / Tuesday, February 21, 2017 / Notices

sradovich on DSK3GMQ082PROD with NOTICES

are submitted will be summarized and
included in the CBP request for OMB
approval. All comments will become a
matter of public record. In this
document, CBP is soliciting comments
concerning the following Information
collection:
Title: Electronic Visa Update System.
OMB Number: 1651–0139.
Form Number: N/A.
Abstract: The Electronic Visa Update
System (EVUS) provides a mechanism
through which visa information updates
can be obtained from certain
nonimmigrant aliens in advance of their
travel to the United States. This
provides CBP access to updated
information without requiring aliens to
apply for a visa more frequently. The
EVUS requirements apply to
nonimmigrant aliens who hold a
passport issued by an identified country
containing a U.S. nonimmigrant visa of
a designated category. EVUS enrollment
is currently limited to nonimmigrant
aliens who hold unrestricted, maximum
validity B–1 (business visitor), B–2
(visitor for pleasure), or combination B–
1/B–2 visas, which are generally valid
for 10 years, contained in a passport
issued by the People’s Republic of
China.
EVUS provides for greater efficiencies
in the screening of international
travelers by allowing DHS to identify
nonimmigrant aliens who may be
inadmissible before they depart for the
United States, thereby increasing
security and reducing traveler delays
upon arrival at U.S. ports of entry.
EVUS aids DHS in facilitating legitimate
travel while also enhancing public
safety and national security.
Proposed Changes
DHS proposes to add the following
optional question to EVUS: ‘‘Please
enter information associated with your
online presence—Provider/Platform—
Social media identifier.’’ A social media
identifier is any name, or ‘‘handle,’’
used by the individual on one or more
platforms. The optional social media
question on the EVUS enrollment will
include a drop down menu of options
for selection. This data will be used for
vetting purposes, as needed, providing
highly trained CBP officers with timely
visibility into publicly available
information on the platforms associated
with the social media identifier(s)
voluntarily provided by the applicant,
along with other information and tools
CBP officers regularly use in the
performance of their duties. The officer
will review said platforms in a manner
consistent with the privacy settings the
applicant has chosen to adopt for those
platforms. It will also help distinguish

VerDate Sep<11>2014

17:15 Feb 17, 2017

Jkt 241001

between individuals with similar
characteristics, such as similar names,
and provide an additional means to
contact an applicant if needed.
Respondents who choose not to answer
this question can still submit an EVUS
enrollment without a negative
interpretation or inference. The question
will be clearly marked as optional.
Current Actions: This submission is
being made to extend the expiration
date with a change to the information
collected as a result of adding an
optional question about social media to
EVUS. There are no changes to the
burden hours.
Type of Review: Revision.
Affected Public: Individuals.
Estimated Number of Respondents:
3,595,904.
Estimated Number of Responses per
Respondent: 1.
Estimated Total Annual Responses:
3,595,904.
Estimated Time per Response: 25
minutes.
Estimated Total Annual Burden
Hours: 1,499,492.
Dated: February 15, 2017.
Seth Renkema,
Branch Chief, Economic Impact Analysis
Branch, U.S. Customs and Border Protection.
[FR Doc. 2017–03343 Filed 2–17–17; 8:45 am]
BILLING CODE P

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 16–34]

Frank D. Li, M.D.; Decision and Order
On August 22, 2016, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Frank D. Li, M.D.
(hereinafter, Respondent), of Tukwila,
Washington and Beverly Hills,
California. The Show Cause Order
proposed the revocation of four separate
Certificates of Registration held by
Respondent (three of which are for
locations in Washington State and one
which is for a location in California),
pursuant to which he is authorized to
dispense controlled substances in
schedules II through V, as a practitioner,
on the ground that he does hold
authority to dispense controlled
substances in these States. Id. at 1
(citing 21 U.S.C. 823(f) and 824(a)(3)).
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Respondent holds three
registrations in Washington State: (1)
No. FL0680947, for the location of 1536

PO 00000

Frm 00068

Fmt 4703

Sfmt 4703

N 115th St., Suite 310, Seattle, which
does not expire until March 31, 2017;
(2) No. FL1688235, for the location of
801 SW 16th St., Suite 121, Renton,
which does not expire until March 31,
2018; and (3) No. FL2601335, for the
location of 3624 Colby Ave., Suite B,
Everett, which does not expire until
March 31, 2017. Show Cause Order, at
2. The Show Cause Order also alleged
that Respondent holds registration No.
BL7067261, for the location of 8641
Wilshire Blvd., Suite 200, Beverly Hills,
California, and that this registration
does not expire until March 31, 2019.
Id.
As for the substantive basis of the
proposed action, the Show Cause Order
alleged that the State of Washington,
Department of Health, issued an ex
parte order, which suspended
Respondent’s authority to practice
medicine and surgery in that State
effective on July 14, 2016. Id. at 2. The
Show Cause Order also alleged that the
Medical Board of California issued an
order which suspended his authority to
practice medicine in that State effective
on August 5, 2016. Id. The Show Cause
Order thus alleged that Respondent is
currently without authority to handle
controlled substances in Washington
and California, the States in which he is
registered with the Agency, and
subjecting his DEA registrations to
revocation.1 Id. at 2 (citing 21 U.S.C.
802(21), 823(f), and 824(a)(3)).
On September 20, 2016, Respondent,
through his counsel, requested a hearing
on the allegations. Resp. Hrng. Req. The
matter was then placed on the docket of
the Office of Administrative Law Judges,
and assigned to ALJ Charles Wm.
Dorman.
On September 21, 2016, the ALJ
issued an order directing the
Government to submit evidence
supporting the allegation and an
accompanying dispositive motion by
October 5, 2016. Briefing Schedule For
Lack Of State Authority Allegations, at
1. The ALJ also ordered that if the
Government filed such a motion,
Respondent was to file his reply by
October 12, 2016. Id.
On September 22, 2016, the
Government filed its Motion for
Summary Disposition. See Gov. Mot. for
Summ. Disp. As support for its Motion,
the Government provided a copy of
Respondent’s registration information
1 The Show Cause Order also notified Respondent
of his right to request a hearing on the allegations
or to submit a written statement while waiving his
right to a hearing, and the procedure for electing
either option. Show Cause Order, at 2–3 (citing 21
CFR 1301.43). It also notified Respondent of his
right to submit a corrective action plan. See 21
U.S.C. 824(c)(2)(C).

E:\FR\FM\21FEN1.SGM

21FEN1